Metformin for treatment of clozapine-induced weight gain in adult patients with schizophrenia: a meta-analysis

Shanghai Archives of Psychiatry

Volumn 27, Issue 6, 2015, Pages 331-340

  Liu, Zhengrong ^a   Zheng, Wei ^b   Gao, Shuai ^a   Qin, Zhisong ^a   Li, Guannan ^a   Ning, Yuping ^b  

^a Guangzhou Civil Affairs Bureau Housing Management   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Clozapine; Clozapine induced weight gain; Meta analysis; Metformin; Schizophrenia

Indexed keywords

EID: 84961252307     PISSN: 10020829     EISSN: None     Source Type: Journal    
DOI: 10.11919/j.issn.1002-0829.215071     Document Type: Article

References (33)

1. Jääskeläinen E, Haapea M, Rautio N, Juola P, Penttilä M, Nordströmet T, et al. Twenty years of schizophrenia research in the Northern Finland birth cohort 1966: a systematic review. Schizophr Res Treatment. 2015; 2015: 524-875. doi: http://dx.doi.org/10.1155/2015/524875
2. Hasnain M, Vieweg WV, Fredrickson SK. Metformin for atypical antipsychotic-induced weight gain and glucose metabolism dysregulation: review of the literature and clinical suggestions. CNS Drugs. 2010; 24(3): 193-206. doi: http://dx.doi.org/10.2165/11530130-000000000-00000
3. Alvarez-Jimenez M, Gonzalez-Blanch CFB, Hetrick S, Rodriguez-Sanchez J, Perez-Iglesias R, Vazquez-Barquero J. Antipsychotic-induced weight gain in chronic and firstepisode psychotic disorders: a systematic critical reappraisal. CNS Drugs. 2008; 22(7): 547-562
4. Wu RR, Jin H, Gao KM, Twamley EW, Ou JJ, Shao F, et al. Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebocontrolled study. Am J Psychiatry. 2012; 169(8): 813-821. doi: http://dx.doi.org/10.1176/appi.ajp.2012.11091432
5. Wu RR, Zhao JP, Guo XF, He YQ, Fang MS, Guo WB, et al. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study. Am J Psychiatry. 2008; 165(3): 352-358. doi: http://dx.doi.org/10.1176/appi.ajp.2007.07010079
6. Wu RR, Zhao JP, Jin H, Shao P, Fang MS, Guo XF, et al. Lifestyle intervention and metformin for treatment of antipsychoticinduced weight gain: a randomized controlled trial. JAMA. 2008; 299(2): 185-193. doi: http://dx.doi.org/10.1001/jama.2007.56-b
7. Carrizo E, Fernandez VL, Connell L, Sandia I, Prieto D, Mogollón J, et al. Extended release metformin for metabolic control assistance during prolonged clozapine administration: a 14 week, double-blind, parallel group, placebo-controlled study. Schizophrenia Res. 2009; 113(1): 19-26. doi: http://dx.doi.org/10.1016/j.schres.2009.05.007
8. Wu RR, Zhang FY, Gao KM, Ou JJ, Shao P, Jin H, et al. Metformin treatment of antipsychotic-induced dyslipidemia: an analysis of two randomized, placebo-controlled trials. Mol Psychiaty. 2016; Epub 26 Jan 2016. doi: http://dx.doi.org/10.1038/mp.2015.221
9. Schaefer M, Leopold K, Hinzpeter A, Heinz A, Krebs M. Memantine-associated reversal of clozapine-induced weight gain. Pharmacopsychiatry. 2007; 40(4): 149-151. doi: http://dx.doi.org/10.1055/s-2007-984391
10. Reis de Sa A Jr, Elkis H. Comments on "Weight gain management in patients with schizophrenia during treatment with olanzapine in association with nizatidine". Rev Bras Psiquiatr. 2007; 29(1): 90. doi: http://dx.doi.org/10.1590/S1516-44462007000100025
11. Behdani F, Hebrani P, Rezaei Ardani A, Rafee E. Effect of topiramate augmentation in chronic schizophrenia: a placebo-controlled trial. Arch Iran Med. 2011; 14(4): 270-275.
12. Zhang YL, Zhang MY. [Field test report on the revision of the second edition of the Chinese Mental Disease Classification and Diagnostic Standard]. Zhong Hua Jing Shen Ke Za Zhi. 1996; 1(1): 27-30. Chinese
13. Chinese Medical Association. [Chinese Mental Disorders Classification and Diagnostic Criteria Third Edition (CCMD-3)]. Jinan: Shandong Science and Technology Press; 2001. Chinese
14. World Health Organization. [Diagnostic criteria for mental and behavioral disorders in ICD-10]. Liu P, Xu YX, translated. Beijing: People's Medical Publishing House; 1995. Chinese
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Text revision. Washington: American Psychiatric Association; 1994
16. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. Washington, D.C: American Psychiatric Association; 2013
17. Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions. Chichester, UK, John: Wiley & Sons; 2008
18. Overall JE, Gorham DR. The Brief Psychiatric Rating-Scale. Psychol Rep. 1962; 10: 799-812
19. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987; 13: 261-276
20. David A, Dana B, Briss PA, Martin E, Yngve FY, Signe F, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004; 328: 1490. doi: http://dx.doi.org/10.1136/bmj.328.7454.1490
21. Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. 2011; Available from: www.cochrane-handbook.org
22. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11): 1539-1558. doi: http://dx.doi.org/10.1002/sim.1186
23. Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel ploy asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011; 343: d4002. doi: http://dx.doi.org/10.1136/bmj.d4002
24. Chen CH, Huang MC, Kao CF, Lin SK, Kuo PH, Chiu CC, et al. Effects of adjunctive metformin on metabolic traits in nondiabetic clozapine-treated patients with schizophrenia and the effect of metformin discontinuation on body weight: a 24-week, randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2013; 74(5): e424-430. doi: http://dx.doi.org/10.4088/JCP.12m08186
25. Liu HP. [Effects of metformin hydrochloride on body mass and blood sugar of convalescence schizophrenics on clozapine]. Lin Chuang Xin Shen Ji Bing Za Zhi. 2012; 18(2): 97-99. Chinese. doi: http://dx.chinadoi.cn/10.3969/j.issn.1672-187X.2012.02.001-0097-03
26. Hebrani P, Manteghi A A, Behdani F, Hessami E, Rezayat KA, Marvast MN, et al. Double-blind, randomized, clinical trial of metformin as add-on treatment with clozapine in treatment of schizophrenia disorder. J Res Med Sci. 2015; 20(4): 364-371
27. Wu W, Wang SR, Han L. [Effect of metformin hydrochloride on weight and blood glucose in the patients with refractory schizophrenia]. Zhongguo Min Kang Yi Xue. 2014; 13: 68-69. Chinese. doi: http://dx.chinadoi.cn/10.3969/j.issn.1672-0369.2014.13.032
28. Zhang JG, Wang ZX. [Effects of metformin on blood glucose, insulin, blood lipid and body weight in schizophrenia patients treated with clozapine]. Zhongguo Shen Jing Jing Shen Ji Bing Za Zhi. 2004; 30(4): 274. Chinese. doi: http://dx.chinadoi.cn/10.3969/j.issn.1002-0152.2004.04.043
29. Wang Y, Zhang XL, Zhu DM, Chu ZX, Gong L, Wu Q. [Metformin for olanzapine-induced weight gain: a metaanalysis]. Zhongguo Jian kang Xin Li Xue Za Zhi. 2014; 5: 653-655, 656. Chinese. doi: http://dx.chinadoi.cn/10.13342/ j.cnki.cjhp.2014.05.006
30. Yi F, Mei J, Su XJ, Mao JY, Zhang YY, Zhen LL. [Metformin for prevention of weight gain in patients with schizophrenia treated with second-generation antipsychotics: a metaanalysis]. Zhong Hua Xing Wei Yi Xue Yu Nao Ke Xue Za Zhi. 2013; 22(3): 221-224. Chinese. doi: http://dx.chinadoi. cn/10.3760/cma.j.issn.1674-6554.2013.03.010
31. Zheng W, Li XB, Tang YL, Xiang YQ., Wang CY, De Leon J. Metformin for weight gain and metabolic abnormalities associated with antipsychotic treatment: metaanalysis of randomized placebo-controlled trials. J Clin Psychopharmacol. 2015; 35(5): 499-509. doi: http://dx.doi.org/10.1097/JCP.0000000000000392
32. Zhen W, Tang LR, Weng YZ, Ma X, Xiang YQ. [Topiramate for prevention of weight gain in patients with schizophrenia treated with second-generation antipsychotics: a Meta-analysis]. Zhongguo Yi Yao. 2015; 10(1): 71-76. Chinese. doi: http://dx.chinadoi.cn/10.3760/cma.j.issn.1673-4777.2015.01.018
33. Mizuno Y, Suzuki T, Nakagawa A, Yoshida K, Mimura M, Fleischhacker WW, et al. Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis. Schizophr Bull. 2014; 40(6): 1385-1403. doi: http://dx.doi.org/10.1093/schbul/sbu030